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The use of positive expiratory pressure therapy does not appear to be effective in
people hospitalised with an acute exacerbation of chronic
obstructive pulmonary disease (AECOPD)SynopsisSummary of: Osadnik CR, McDonald CF, Miller BR, Hill CJ, Tarrant B,
Steward R, et al. The effect of positive expiratory pressure (PEP) therapy on
symptoms, quality of life and incidence of re-exacerbation in patients with
acute exacerbations of chronic obstructive pulmonary disease: a multi-
centre, randomised controlled trial. Thorax 2014;69:137-143.
Question: In people who are hospitalised with an acute exacerbation of
chronic obstructive pulmonary disease (AECOPD), does the addition of
positive expiratory pressure (PEP) therapy to usual medical care improve
symptoms and reduce the incidence of future exacerbations? Design: Multi-
centre, randomised, controlled trial with concealed allocation and blinding of
outcome assessors. Setting: Two public tertiary hospitals in Melbourne,
Australia. Participants: Adults who were hospitalised with AECOPD were
included if they had a history of chronic sputum production and were within
48 hours of admission. Exclusion criteria were: a history of a chronic lung
condition more signiﬁcant than their COPD, established airway clearance
routines, the need for an artiﬁcial airway, or a contraindication to PEP therapy.
Randomisation allocated 46 people each to the intervention and control
groups. Interventions: Participants inbothgroups receivedusualmedical care
in accordance with COPD-X guidelines and a standard exercise-training
program. Those in the intervention group performed additional PEP therapy
via a facemask, in an upright position, three times a day (one session was
supervised). During each session, the participants took 8 to 10 tidal volume
breaths andused a slightly active expiration to achieve an expiratory pressure
of 10 to 20 cmH2O, followed by one huff at low-lung volume, one huff
from mid-lung volume and two strong coughs. This sequence was repeated
ﬁve times each session. Outcome measures: The primary outcome was1836-9553/Crown Copyright  2014 Published by Elsevier B.V. on behalf of Australianself-reported symptom severity, measured using the Breathlessness, Cough
and Sputum Scale at hospital discharge, 8 weeks, and 6 months following
discharge. Other outcomes included: functional limitation due to dyspnoea,
health-related quality of life, the need for ventilatory assistance, length of
hospital stay and the number of acute exacerbations over the ﬁrst 6 months
following discharge. Results: A total of 88 participants completed the study.
There were no between-group differences in the Breathlessness, Cough and
Sputum Scale at hospital discharge (0.2 units, 95% CI –0.9 to 1.4), or at any
other time point. Those in the intervention group had less functional
limitation due to dyspnoea 8 weeks following discharge (between-group
difference –0.4 units, 95% CI –0.5 to –0.3), but this was not maintained at
6 months following discharge. There were no between-group differences in
the other outcomes at any time point. Conclusion: In people who are
hospitalised with AECOPD and are characterised by chronic sputum
production, PEP therapy may produce a short-term reduction in functional
limitation due todyspnoea, butnot affect symptoms, health-relatedquality of
life, the need for ventilatory assistance, length of hospital stay or the future
incidence of acute exacerbations.Kylie Hill
School of Physiotherapy and Exercise Science, Curtin University
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physiotherapists use a variety of airway clearance techniques to treat
patients during acute exacerbations of chronic obstructive pulmonary
disease (AECOPD).2 This lack of evidence calls for further clinical trials, as
performing airway clearance techniques is time consuming and costly, if
purchasing devices.
The multi-centre, randomised, controlled trial by Osadnik et al
investigated the effects of positive expiratory pressure (PEP) therapy during
AECOPD. This technique was chosen based on the theory that resistance
during expiration prevents dynamic airway collapse, moves the equal
pressure point peripherally, and may reduce dynamic hyperinﬂation and
dyspnoea.
Choosing outcomemeasures for an airway clearance technique study can
be difﬁcult. The primary outcome measure used in this trial was the
Breathlessness, Cough and Sputum Scale, which is clinically relevant as these
symptoms impact on the daily life of those with COPD. Using expectorated
sputumas anoutcomemeasure hasﬂaws and thereforewasnot included. The
effect of PEP on health-related quality of life and healthcare utilisation was
also investigated. This high-quality and adequately powered trial found that
theadditionofPEP tousual care conferrednoshort-termor long-termbeneﬁts
to the person or healthcare service. It is worth noting that this trial excludedthose who have signiﬁcant bronchiectasis and, during an exacerbation, this
group is likely to beneﬁt from airway clearance techniques.
These ﬁndings indicate that airway clearance techniques, in particular
PEP, should not be included as part of routine physiotherapy care for people
who are hospitalisedwith AECOPD. Given the beneﬁts of exercise training in
this clinical population,3 an alternative for people who experience difﬁculty
in clearing airway secretions may be hufﬁng intermittently during exercise,
which itself increases tidal volume and expiratory ﬂow.
Jamie Wood
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